Exploring the genetic blueprint of cerebrospinal fluid proteins, this study uncovers new markers and therapeutic targets that may unlock advancements in Alzheimer’s diagnosis and care. Study: ...

For much of the past century, Alzheimer's disease has been one of medicine's most daunting frontiers - biologically complex, ...

CIDP causes muscle weakness and numbness, among other symptoms. Diagnosing CIDP involves peripheral nervous system testing, cerebrospinal fluid analysis, and imaging. CIDP is an immune-mediated ...

Immune cells accessing cerebrospinal fluid faithfully recapitulate the characteristics of cells identified in brain metastasis, and could therefore constitute novel biomarkers of response to ...

For many years, the only antemortem clinical laboratory test available for prion disease was limited to the detection of 14-3-3 and total Tau proteins in CSF. As rapid neurodegeneration is a hallmark ...

How Is a CSF Glucose Test Done? The most common way to check the glucose in your cerebrospinal fluid is by performing a lumbar puncture, also called a spinal tap. In some cases, your doctor can also ...

The government's new vision for dementia diagnosis is ambitious: by 2029, more than 92 per cent of patients could receive a ...

Cognito Therapeutics Announces Presentation of New CSF Proteomic and EEG Biomarker Data for Spectris™ in Alzheimer’s Disease ...